BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38641602)

  • 1. Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey.
    Okyere J; Ayebeng C; Dosoo AK; Dickson KS
    BMC Public Health; 2024 Apr; 24(1):1093. PubMed ID: 38641602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
    BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Côte d'Ivoire demographic and health survey.
    Okyere J; Ayebeng C; Dickson KS
    BMC Health Serv Res; 2024 Apr; 24(1):423. PubMed ID: 38570834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socio-demographic determinants of cervical cancer screening uptake among women of child-bearing age in Mangochi, Malawi: a facility-based cross-sectional study.
    Mpachika-Mfipa F; Kululanga LI; Kazembe A; Mfipa D
    BMC Cancer; 2022 Oct; 22(1):1096. PubMed ID: 36289460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.
    Kimondo FC; Kajoka HD; Mwantake MR; Amour C; Mboya IB
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1374. PubMed ID: 33739611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys.
    Okyere J; Duodu PA; Aduse-Poku L; Agbadi P; Nutor JJ
    BMC Public Health; 2021 Jun; 21(1):1071. PubMed ID: 34090372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating HIV testing into cervical cancer screening in Tanzania: an analysis of routine service delivery statistics.
    Plotkin M; Besana GV; Yuma S; Kim YM; Kulindwa Y; Kabole F; Lu E; Giattas MR
    BMC Womens Health; 2014 Sep; 14():120. PubMed ID: 25271025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
    BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wealth-related inequalities of women's knowledge of cervical cancer screening and service utilisation in 18 resource-constrained countries: evidence from a pooled decomposition analysis.
    Mahumud RA; Keramat SA; Ormsby GM; Sultana M; Rawal LB; Alam K; Gow J; Renzaho AMN
    Int J Equity Health; 2020 Mar; 19(1):42. PubMed ID: 32216799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening uptake and correlates among HIV-infected women: a cross-sectional survey in Côte d'Ivoire, West Africa.
    Tchounga B; Boni SP; Koffi JJ; Horo AG; Tanon A; Messou E; Koulé SO; Adoubi I; Ekouevi DK; Jaquet A
    BMJ Open; 2019 Aug; 9(8):e029882. PubMed ID: 31473620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
    Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
    Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of uptake of cervical cancer screening among women in Urban Tanzania: community-based cross-sectional study.
    Mboineki JF; Wang P; Dhakal K; Getu MA; Millanzi WC; Chen C
    Int J Public Health; 2020 Dec; 65(9):1593-1602. PubMed ID: 33130908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study.
    Mpachika-Mfipa F; Kululanga LI; Mfipa D; Kazembe A
    BMC Womens Health; 2023 Jun; 23(1):334. PubMed ID: 37355588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and cervical cancer screening among women aged 15-69 years in Eswatini: evidence from a population-based survey.
    Motsa MPS; Estinfort W; Phiri YVA; Simelane MS; Ntenda PAM
    BMC Public Health; 2023 Aug; 23(1):1638. PubMed ID: 37635230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
    Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
    Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
    Zhang D; Advani S; Huchko M; Braithwaite D
    BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Peer-Led Navigation Approach as a Form of Task Shifting in Promoting Cervical Cancer Screening Knowledge, Intention, and Practices Among Urban Women in Tanzania: A Randomized Controlled Trial.
    Mboineki JF; Wang P; Dhakal K; Getu MA; Chen C
    Cancer Control; 2022; 29():10732748221089480. PubMed ID: 35666651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    Tron L; Lert F; Spire B; Dray-Spira R;
    HIV Med; 2017 Mar; 18(3):181-195. PubMed ID: 28967199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.
    Gebreegziabher ZA; Semagn BE; Kifelew Y; Abebaw WA; Tilahun WM
    BMC Public Health; 2024 Mar; 24(1):741. PubMed ID: 38459446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.